AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION
Authors: CARLENS S RINGDEN O ASCHAN J HAGGLUND H LJUNGMAN P MATTSSON J REMBERGER M
Citation: S. Carlens et al., RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION, Clinical transplantation, 12(2), 1998, pp. 84-92
RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Authors: CARLENS S RINGDEN O REMBERGER M LONNQVIST B HAGGLUND H KLAESSON S MATTSSON J SVAHN BM WINIARSKI J LJUNGMAN P ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION
Authors: SPARRELID E HAGGLUND H REMBERGER M RINGDEN O LONNQVIST B LJUNGMAN P ANDERSSON J
Citation: E. Sparrelid et al., BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION, Bone marrow transplantation, 22(8), 1998, pp. 795-800
DETECTION OF HEPATITIS-G VIRUS GB-VIRUS-C AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: LJUNGMAN P HALASZ R HAGGLUND H SONNERBORG A RINGDEN O
Citation: P. Ljungman et al., DETECTION OF HEPATITIS-G VIRUS GB-VIRUS-C AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 499-501
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 22(2), 1998, pp. 131-136
BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: REMBERGER M RINGDEN O LJUNGMAN P HAGGLUND H WINIARSKI J LONNQVIST B ASCHAN J
Citation: M. Remberger et al., BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(1), 1998, pp. 73-78
INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW
Authors: HAGGLUND H RINGDEN O AGREN B WENNBERG L REMBERGER M RUNDQUIST L SVAHN BM ASPELIN P
Citation: H. Hagglund et al., INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW, Bone marrow transplantation, 21(4), 1998, pp. 331-335
OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS
Authors: HAGGLUND H RINGDEN O LONNQVIST B SPARRELID E REMBERGER M KUMLIEN G
Citation: H. Hagglund et al., OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 42-42
FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS
Authors: RINGDEN O HAGGLUND H RUNDE V BASU O KROSCHINSKY F STOCKSCHLADER M POTTER MN
Citation: O. Ringden et al., FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 81-84
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J CARLENS S HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Bone marrow transplantation, 21(1), 1998, pp. 43-49
A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT
Authors: HAGGLUND H RINGDEN O OHMAN S REMBERGER M CARLENS S MATTSSON J
Citation: H. Hagglund et al., A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT, Bone marrow transplantation, 21, 1998, pp. 113-113
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES, Bone marrow transplantation, 21, 1998, pp. 114-114
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 21, 1998, pp. 143-143
BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS
Authors: HENTSCHKE P HAGGLUND H MATTSSON J CARLENS S LONNQVIST B LJUNGMAN P ASCHAN J RINGDEN O
Citation: P. Hentschke et al., BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21, 1998, pp. 326-326
CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS
Authors: KLAESSON S HAGGLUND H LJUNGMAN P CARLENS S MATTSSON J REMBERGER M SPARRELID E WINIARSKI J RINGDEN O
Citation: S. Klaesson et al., CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 415-415
DETECTION OF HEPATITIS-G VIRUS (HGV) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: LJUNGMAN P HALASZ R HAGGLUND H SONNERBORG A RINGDEN O
Citation: P. Ljungman et al., DETECTION OF HEPATITIS-G VIRUS (HGV) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Bone marrow transplantation, 21, 1998, pp. 526-526
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E ELMHORNROSENBORG A SVAHN BM LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES, Transplantation, 66(5), 1998, pp. 620-625
TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM UNRELATED DONORS
Authors: RINGDEN O RUNDE V HAGGLUND H BASU O POTTER M
Citation: O. Ringden et al., TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM UNRELATED DONORS, Transplantation, 66(1), 1998, pp. 142-143
INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: CARRERAS E BERTZ H ARCESE W VERNANT JP TOMAS JF HAGGLUND H BANDINI G ESPEROU H RUSSELL J DELARUBIA J DIGIROLAMO G DEMUYNCK H HARTMANN O CLAUSEN J RUUTU T LEBLOND V IRIONDO A BOSI A BENBASSAT I KOZA V GRATWOHL A APPERLEY JF
Citation: E. Carreras et al., INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 92(10), 1998, pp. 3599-3604
PEROPERATIVE TEICOPLANIN FOR PREVENTION OF GRAM-POSITIVE INFECTIONS IN NEUTROPENIC PATIENTS WITH INDWELLING CENTRAL VENOUS CATHETERS - A RANDOMIZED, CONTROLLED-STUDY
Authors: LJUNGMAN P HAGGLUND H BJORKSTRAND B LONNQVIST B RINGDEN O
Citation: P. Ljungman et al., PEROPERATIVE TEICOPLANIN FOR PREVENTION OF GRAM-POSITIVE INFECTIONS IN NEUTROPENIC PATIENTS WITH INDWELLING CENTRAL VENOUS CATHETERS - A RANDOMIZED, CONTROLLED-STUDY, Supportive care in cancer, 5(6), 1997, pp. 485-488
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN P REMBERGER M MATTSSON J ASCHAN J HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: P. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Experimental hematology, 25(8), 1997, pp. 33-33
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H CARLENS S LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Transplantation proceedings, 29(7), 1997, pp. 3145-3146
FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H LJUNGMAN P
Citation: S. Carlens et al., FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Transplantation proceedings, 29(7), 1997, pp. 3147-3149
A LOW INCIDENCE OF GRADE-II TO GRADE-IV ACUTE GVHD, BUT HIGH MORTALITY FROM, INFECTION USING HLA-A, HLA-B, AND HLA-DR-IDENTICAL UNRELATED DONORS AND IMMUNOSUPPRESSION WITH ATG, CYCLOSPORINE, AND METHOTREXATE
Authors: MATTSSON J RINGDEN O ASCHAN J BARKHOLT L DALIANIS T HAGGLUND H LJUNGMAN P LONNQVIST B TOLLEMAR J WINIARSKI J REMBERGER M
Citation: J. Mattsson et al., A LOW INCIDENCE OF GRADE-II TO GRADE-IV ACUTE GVHD, BUT HIGH MORTALITY FROM, INFECTION USING HLA-A, HLA-B, AND HLA-DR-IDENTICAL UNRELATED DONORS AND IMMUNOSUPPRESSION WITH ATG, CYCLOSPORINE, AND METHOTREXATE, Transplantation proceedings, 29(1-2), 1997, pp. 735-736
SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A 2.5-YEAR-OLD BOY WITH ONGOING CYTOMEGALOVIRUS VIREMIA AND SEVERE APLASTIC-ANEMIA AFTER ORTHOTOPIC LIVER-TRANSPLANTATION ON FOR NON-A, NON-B, NON-C HEPATITIS
Authors: HAGGLUND H WINIARSKI J RINGDEN O SPARRELID E ERICZON BG
Citation: H. Hagglund et al., SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A 2.5-YEAR-OLD BOY WITH ONGOING CYTOMEGALOVIRUS VIREMIA AND SEVERE APLASTIC-ANEMIA AFTER ORTHOTOPIC LIVER-TRANSPLANTATION ON FOR NON-A, NON-B, NON-C HEPATITIS, Transplantation, 64(8), 1997, pp. 1207-1208
Risultati: 1-25 | 26-38